Hilde Furberg

This profile gathers the share dealings of Hilde Furberg in Calliditas Therapeutics AB. We count 5 filings; the first trade dates from 17 June 2020 and the latest from 2 September 2024.

The open-market record consists of 1 sale worth €1.0M, with no purchase. Besides market trades, the filings include 2 share grants. In 2024 alone, the filings show no purchases and 1 sale.

Most recently, on 4 September 2024, the filings show an open-market sale worth €1.0M in Calliditas Therapeutics AB. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.